Evidence map›Paper›PMID 35840301›Full record

ArticleBMJ open2022

Perspectives on adapting a mobile application for pain self-management in neurofibromatosis type 1: results of online focus group discussions with individuals living with neurofibromatosis type 1 and pain management experts.

Lauretta E Grau, Kaitlyn Larkin, Chitra Lalloo, Jennifer N Stinson, William T Zempsky, Samuel A Ball, Frank D Buono

Open access · goldAbstract read
In one paragraph

Article in BMJ open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Lauretta E GrauDepartment of Epidemiology of Microbial Diseases, Yale University Yale School of Public Health, New Haven, Connecticut, USA lauretta.grau@yale.edu.ORCID 0000-0003-4985-8019
Kaitlyn LarkinDepartment of Psychiatry, Yale School of Medicine, New Haven, Connecticut, USA.
Chitra LallooChild Health Evaluative Sciences, The Hospital for Sick Children, Toronto, Ontario, Canada.
Jennifer N StinsonInstitute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.
William T ZempskyDepartment of Pediatrics and Nursing, University of Connecticut School of Medicine, Farmington, Connecticut, USA.
Samuel A BallDepartment of Psychiatry, Yale School of Medicine, New Haven, Connecticut, USA.
Frank D BuonoDepartment of Psychiatry, Yale School of Medicine, New Haven, Connecticut, USA.
Yale University · USUniversity of Toronto · CAUniversity of Connecticut · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
NCATS NIH HHS UL1 TR001863
6 · The paper itself

Abstract

objectiveNeurofibromatosis type 1 (NF1) is a genetic disorder in which chronic pain commonly occurs. The study sought to understand the needs of individuals with NF1 and pain management experts when adapting a pain self-management mobile health application (app) for individuals with NF1.

designWe conducted a series of online, audio-recorded focus groups that were then thematically analysed.

settingOnline focus groups with adults currently residing in the USA.

participantsTwo types of participants were included: individuals with NF1 (n=32 across six focus groups) and pain management experts (n=10 across three focus groups).

resultsSix themes across two levels were identified. The individual level included lifestyle, reasons for using the mobile app and concerns regarding its use. The app level included desired content, desired features and format considerations. Findings included recommendations to grant free access to the app and include a community support feature for individuals to relate and validate one another's experience with pain from NF1. In addition, participants noted the importance of providing clear instructions on navigating the app, the use of an upbeat, hopeful tone and appropriate visuals.

conclusionsBoth participant groups endorsed the use of iCanCope (iCC) as an NF1 pain self-management mobile app. Differences between groups were noted, however. The NF1 group appeared interested in detailed and nuanced pain tracking capabilities; the expert group prioritised tracking information such as mood, nutrition and activity to identify potential associations with pain. In tailoring the existing iCC app for individuals with NF1, attention should be paid to creating a community support group feature and to tailoring content, features and format to potential users' specific needs.

Indexed as

Chronic PainMobile ApplicationsNeurofibromatosis 1Self-ManagementAdultFocus GroupsHumansPain ManagementAdult neurologyCOMPLEMENTARY MEDICINENeurogeneticsNeurological painPAIN MANAGEMENTQUALITATIVE RESEARCH

Identifiers

PMID35840301
PMCPMC9295671
OpenAlexW4285500681

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.